Risk of coronary artery disease in patients with gout on treatment with Colchicine: A systematic review and meta-analysis
Background: Colchicine has anti-inflammatory properties, but its utility in improving cardiovascular outcomes has been disputed. Here, we study the impact of colchicine on cardiovascular outcomes in patients with gout with and without coronary artery disease (CAD). Methods: Medline, Web of Science a...
Main Authors: | Muhammad U. Siddiqui, Joey Junarta, Swaminathan Sathyanarayanan, Kirpal Kochar, Waqas Ullah, David L. Fischman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-04-01
|
Series: | International Journal of Cardiology: Heart & Vasculature |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352906723000222 |
Similar Items
-
Colchicine as an Adjuvant Therapy for Coronary Artery Disease: A Systematic Review
by: Nobian Andre, et al.
Published: (2020-11-01) -
Colchicine for gout
by: M. S. Eliseev, et al.
Published: (2021-08-01) -
Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta‐Analysis of Randomized Trials
by: Thomas Kofler, et al.
Published: (2021-08-01) -
COLCHICINE IS ASSOCIATED WITH LOWER CARDIOVASCULAR MORBIDITY IN GOUT
by: Claudiu Popescu, et al.
Published: (2016-12-01) -
Colchicine in the Management of Acute Coronary Syndrome: A Meta-analysis
by: Jason Nogic, et al.
Published: (2023-01-01)